Diagnostics & Research
The Diagnostics & Research industry has a total of 50 stocks, with a combined market cap of $783.95 billion, total revenue of $166.43 billion and a weighted average PE ratio of 52.49.
Market Cap
783.95B
Revenue
166.43B
Profits
14.94B
PE Ratio
52.49
Profit Margin
8.97%
Dividend Yield
0.18%
50 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 213.48B | -0.80% | 1,412,169 | 43.74B |
| 2 | DHR | Danaher Corporation | 158.56B | -0.78% | 2,940,750 | 24.27B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 56.43B | -1.04% | 411,923 | 4.17B |
| 4 | A | Agilent Technologies, Inc. | 40.32B | -2.10% | 2,195,284 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 38.07B | -1.01% | 1,269,823 | 15.90B |
| 6 | NTRA | Natera, Inc. | 33.00B | -2.21% | 1,296,430 | 2.12B |
| 7 | MTD | Mettler-Toledo International Inc. | 28.22B | -2.37% | 189,200 | 3.94B |
| 8 | WAT | Waters Corporation | 23.38B | -0.52% | 675,953 | 3.11B |
| 9 | LH | Labcorp Holdings Inc. | 21.55B | 0.60% | 558,601 | 13.77B |
| 10 | DGX | Quest Diagnostics Incorporated | 20.23B | -0.38% | 980,690 | 10.85B |
| 11 | ILMN | Illumina, Inc. | 19.44B | -1.33% | 1,201,656 | 4.29B |
| 12 | EXAS | Exact Sciences Corporation | 19.16B | -0.10% | 8,894,026 | 3.08B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.47B | 0.19% | 216,850 | 2.36B |
| 14 | ICLR | ICON Public Limited Company | 13.91B | -2.03% | 1,017,875 | 8.10B |
| 15 | GH | Guardant Health, Inc. | 13.42B | 2.11% | 1,881,055 | 902.57M |
| 16 | RVTY | Revvity, Inc. | 11.31B | -0.99% | 2,156,276 | 2.81B |
| 17 | QGEN | Qiagen N.V. | 9.94B | -2.45% | 1,353,519 | 2.07B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.21B | 1.52% | 810,782 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.88B | -3.09% | 700,925 | 1.97B |
| 20 | BLLN | BillionToOne, Inc. | 4.75B | -6.25% | 212,212 | 209.03M |
| 21 | SHC | Sotera Health Company | 4.72B | -0.90% | 4,674,054 | 1.15B |
| 22 | WGS | GeneDx Holdings Corp. | 4.62B | 0.53% | 385,859 | 402.19M |
| 23 | GRAL | GRAIL, Inc. | 3.89B | -1.17% | 820,138 | 141.83M |
| 24 | VCYT | Veracyte, Inc. | 3.51B | -0.56% | 977,451 | 495.14M |
| 25 | TWST | Twist Bioscience Corporation | 1.97B | -0.25% | 1,875,015 | 376.57M |
| 26 | NEO | NeoGenomics, Inc. | 1.52B | -1.60% | 1,851,774 | 709.16M |
| 27 | NEOG | Neogen Corporation | 1.31B | 1.00% | 1,994,505 | 886.89M |
| 28 | CSTL | Castle Biosciences, Inc. | 1.11B | -1.40% | 332,151 | 343.53M |
| 29 | OPK | OPKO Health, Inc. | 1.01B | -1.49% | 5,111,388 | 642.07M |
| 30 | CDNA | CareDx, Inc | 972.08M | 2.00% | 970,690 | 358.00M |
| 31 | PSNL | Personalis, Inc. | 872.06M | 2.72% | 1,363,872 | 69.10M |
| 32 | FLGT | Fulgent Genetics, Inc. | 861.22M | 0.25% | 203,274 | 315.55M |
| 33 | MYGN | Myriad Genetics, Inc. | 659.02M | -0.28% | 891,242 | 825.30M |
| 34 | PRE | Prenetics Global Limited | 240.98M | 2.36% | 119,901 | 77.08M |
| 35 | BNR | Burning Rock Biotech Limited | 195.95M | -9.00% | 56,179 | 75.75M |
| 36 | MDXH | MDxHealth SA | 173.74M | -2.50% | 61,381 | 103.07M |
| 37 | XGN | Exagen Inc. | 158.42M | -2.92% | 278,205 | 63.60M |
| 38 | IMDX | Insight Molecular Diagnostics Inc. | 141.60M | -5.73% | 22,245 | 4.40M |
| 39 | FONR | FONAR Corporation | 93.81M | -1.98% | 26,040 | 105.43M |
| 40 | BDSX | Biodesix, Inc. | 61.97M | 1.43% | 240,237 | 80.17M |
| 41 | PRPO | Precipio, Inc. | 43.55M | 3.50% | 5,054 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 28.52M | 2.76% | 401,758 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 10.01M | 2.83% | 59,712 | - |
| 44 | ADVB | Advanced Biomed Inc. | 7.83M | -5.51% | 133,567 | - |
| 45 | BIAF | bioAffinity Technologies, Inc. | 7.41M | 1.23% | 38,003 | 6.78M |
| 46 | NDRA | ENDRA Life Sciences Inc. | 6.39M | -8.05% | 48,672 | - |
| 47 | PRPH | ProPhase Labs, Inc. | 6.37M | 6.15% | 1,893,411 | 5.06M |
| 48 | MYNZ | Mainz Biomed N.V. | 5.85M | -6.90% | 83,188 | 659.94K |
| 49 | ISPC | iSpecimen Inc. | 4.69M | -0.68% | 171,604 | 3.35M |
| 50 | XWEL | XWELL, Inc. | 4.53M | -0.77% | 11,415 | 29.52M |